Brand plans, demand forecasting and P&L ownership for pharma portfolios up to £2.6M, from the annual plan to monthly tracking against target.
Brand plans, demand forecasting and P&L ownership for pharma portfolios up to £2.6M, from the annual plan to monthly tracking against target.